Ekos Corporation
EKOS Corporation is a medical device company that has developed a proprietary ultrasound-enhanced catheter designed to improve the performance of therapeutic drugs used to treat ischemic strokes and vascular occlusions.
EKOS Corporation is a medical device company that has developed a proprietary ultrasound-enhanced catheter designed to improve the performance of therapeutic drugs used to treat ischemic strokes and vascular occlusions. These symptoms occur when thrombus clogs blood vessels in brain or body and blood flow stops. Since removal of thrombus and recovering blood flow solves the problem, thrombolytic agent is used in thrombolytic therapy. However, often times, this is not enough to completely dissolve intertwined thrombolytic, and a new therapeutic method is desired. At Ekos, ultrasound-enhanced catheter is developed to significantly improve the ability of thrombolytic agent.
| Company | Ekos Corporation |
|---|---|
| URL | http://www.ekoscorp.com/ |
With no evidence of thrombus breakage or hemolysis
Bothell, Wash. – March 18, 2008 – EKOS® Corporation, the leader in the emerging field of microsonic accelerated thrombolysis (MAT), today introduced a new endovascular device that is 29 centimeters (roughly 30 percent) longer.
Presentations Highlight Advantages of EKOS EndoWaveR Ultrasound Accelerated Thrombolysis in Treating Both Peripheral Arterial and Venous Disease
EKOS to be Honored as Tibbetts Award Winner
Washington, D.C. - EKOS Corporation of Bothell, Washington has been selected as one of the winners of the 2006 Tibbetts Awards. Doug Hansmann will receive the award on Sept. 26 at the Wyndham Washington, located at 1400 M Street NW in Washingt...
EKOS(R) Develops new treatment for ischemic stroke using ultrasound contrast agents with $250 K
EKOS Corporation announced today that it has received $250,000.00 from the National Institute for Neurological Disorder and Stroke (NINDS), a division of National Institutes of Health (NIH), to develop an ischemic stroke therapy that provides faster ...
Ekos(R) Corporation Establishes Sales And Marketing Team Following Completion Of $26 Million Series C Financing
Investment to Help Drive Adoption of Ultrasound-Assisted Technology for Treatment of Peripheral Vascular Diseases
EKOS' Micro-Infusion Catheter Utilized in National Institutes of Health (NIH)-Sponsored Trial That Demonstrated a Trend in Better Outcomes for Victims of Ischemic Stroke
NIH Sponsored Trial Shows Ultrasound Microcatheter Improves Blood Flow in Ischemic Stroke Patients
Venice, Italy --Oct 20, 2005. At the VIII Congress of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) meeting today, Dr. Thomas Tomsick of the University of Cincinnati presented data that further supports the con...
11/01/2010MVC Corporation Changes Name to Mitsui & Co. Global Investment, Ltd.
11/01/2010MCVP Changes Name and Relocates Office
09/27/2010Notice on Relocation of MVC Head Office
09/24/2010Mitsui Ventures invested USD 5 M in S*BIO
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.